Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5243]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo
Dr Amir Fathi, Massachusetts General Hospital, Boston, USA
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo ( Dr Amir Fathi, Massachusetts General Hospital, Boston, USA )
11 Jun 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma...
Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )
11 Jun 2016
RNA regulation of JAK-STAT pathways in CML
Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA
RNA regulation of JAK-STAT pathways in CML ( Prof Danilo Perrotti - The University of Maryland Baltimore, Baltimore, USA )
10 Jun 2016
Stopping tyrosine kinase inhibitors in CML
Dr Johan Richter - Lund University, Sweden
Stopping tyrosine kinase inhibitors in CML ( Dr Johan Richter - Lund University, Sweden )
10 Jun 2016
Evaluation of ibrutinib in treatment of CLL with 17p deletion
Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA
Evaluation of ibrutinib in treatment of CLL with 17p deletion ( Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA )
10 Jun 2016
Sequencing analysis with circulating DNA
Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA
Sequencing analysis with circulating DNA ( Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA )
6 Jun 2016
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma
Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )
6 Jun 2016
Daratumumab slows progression in refractory multiple myeloma
Prof Palumbo - University of Turin, Turin, Italy
Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )
6 Jun 2016
Recent developments in targeted therapies
Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016
MyPathway guidance of targeted therapy based on molecular profiles
Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016
Upfront autologous stem cell transplantation for newly diagnosed multiple...
Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy
Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma ( Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy )
6 Jun 2016
Advanced RET-rearranged NSCLC
Dr Takashi Seto and Dr Kiyotaka Yoh
Advanced RET-rearranged NSCLC ( Dr Takashi Seto and Dr Kiyotaka Yoh )
6 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation